Risk Of Drug Induced Liver Injury Associated With The Use Of Metamizole-containing Medicines

Risk Of Drug Induced Liver Injury Associated With The Use Of Metamizole-containing Medicines

Sanofi-Aventis South Africa (Pty) Ltd and Adcock Ingram Ltd in agreement with the South African Health Products Regulatory Authority (SAHPRA) would like to inform you about the risk of drug induced liver injury (DILI) associated with the use of metamizole-containing medicines

2021 Mar

Download latest version
File Type: pdf
Category: Communication To Health Care Professionals
Unit: pharmacovigilance